Madrid

• Evaluation of efficacy and safety of early in hospital initiation of inclisiran treatment in patients with acute coronary syndromes Recruiting
  2025-521670-34-00 5 2026-03-04 Acute coronary syndrome (ST-elevation myocardial infarction [STEMI] or
• An induction study to investigate the efficacy and safety of duvakitug in participants with moderately to severely active Ulcerative Colitis Recruiting
  2025-521035-37-00 5 2026-03-02 Immune system diseases
• A Randomized, Open-labelled, Multicenter Trial Evaluating Efficacy and Safety of A Reduced Venetoclax Exposure To Seven Days Versus Standard … Recruiting
  2025-521634-29-00 5 2026-03-02 Acute Myeloid Leukemia
• Effect of intravenous iron on quality of life in older adults with acute coronary syndrome: a phase IV clinical study Recruiting
  2025-522421-36-00 6 2026-02-27 Acute coronary syndrome
• A Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Rilvegostomig in Adult Participants with Advanced Solid Tumors Previo … Recruiting
  2025-521614-26-00 3 2026-02-26 Advanced Solid Tumors
• Phase 2b/3 Study to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants Receiving Bulevirtide Recruiting
  2025-522015-42-00 10 2026-02-26 Chronic Hepatitis D Infection
• EFFICACY OF FARICIMAB IN PATIENTS WITH SUBRETINAL HYPER-REFLECTIVE MATERIAL Recruiting
  2025-522701-38-00 6 2026-02-26 SUBRETINAL HYPERREFLECTIVE MATERIAL
• Radiopharmaceutical treatment of advanced kidney cancer Recruiting
  2024-517899-38-00 4 2026-02-25 Clear Cell Renal Cell Carcinoma (ccRCC)
• A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratum … Recruiting
  2025-520897-21-00 10 2026-02-25 Multiple Myeloma
• Glo-BNHL: A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma Recruiting
  2024-510575-38-00 10 2026-02-24 Relapsed and refractory mature B-cell non-Hodgkin Lymphoma
• A study to evaluate IPN10200 safety and efficacy in the prevention of episodic or chronic migraine in adults Recruiting
  2024-511101-28-00 4 2026-02-24 Episodic Migraine Chronic Migraine
• Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer (OPERA-02) Recruiting
  2025-522873-12-00 5 2026-02-24 ER+, HER2- Advanced Breast Cancer
• Effects of ziltivekimab on coronary atherosclerotic burden in patients with acute myocardial infarction Recruiting
  2024-520364-34-00 5 2026-02-23 Acute myocardial infarction
• Inhibiting BCL-2 at the start of HIV treatment to reduce the HIV reservoir in people living with HIV Recruiting
  2025-521841-26-00 9 2026-02-20 HIV-1 infection
• ROC-101 Safety and Tolerability Study in Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung … Recruiting
  2025-522074-37-00 4 2026-02-19 Pulmonary Arterial Hypertension (PAH), Pulmonary Hypertension Associat
• A trial to learn how safe Dato-DXd is and how well it works in people with NSCLC that has advanced after receiving osimertinib Recruiting
  2024-511362-37-00 5 2026-02-18 Non squamous non-small cell lung cancer (NSCLC)
• A Phase 1 Study for ZW191 in Participants with Solid Tumors Recruiting
  2024-512299-37-00 1 2026-02-18 Advanced solid tumors
• A Phase 1, First-in-Human Study of MEN2312, a KAT6 inhibitor, as Monotherapy and in Combination in Participants with Advanced Breast Cancer Recruiting
  2024-514661-19-01 1 2026-02-18 Advanced ER+/HER2- Breast Cancer
• Patient-Centered Study of T-DXd in Metastatic HER2-Positive Breast Cancer with Real-Life Side Effect Management Recruiting
  2025-521805-41-00 5 2026-02-18 Patients with HER2-positive, locally advanced or metastatic breast can
• A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Anti-tumour Activity of IPN01203 in Adult … Recruiting
  2025-522184-15-00 7 2026-02-18 Advanced Solid Tumor, Metastatic Solid Tumor
• A Clinical Trial to learn about the effects of TLN-372 when given Alone and in Combination with Other Anti-Tumor Agents in people with Advan … Recruiting
  2025-523086-22-00 7 2026-02-18 Locally advanced or metastatic solid tumors
• A Phase 2, Randomized, Open-Label Study Of Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft Versus Host … Recruiting
  2025-521849-25-00 4 2026-02-17 Chronic Graft-Versus-Host Disease
• A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer Recruiting
  2025-521904-23-00 4 2026-02-17 Locally Advanced Inoperable or Metastatic Breast Cancer Refractory to
• Maridebart Cafraglutide versus Placebo in Adult Participants with Obstructive Sleep Apnea on Positive Airway Pressure Therapy (MARITIME-OSA- … Recruiting
  2025-522703-14-00 5 2026-02-17 "Moderate to severe obstructive sleep apnea (OSA) in adults living wit

Showing 721–744 of 3,550 trials